🔗 Share this article

Grammy-winning soul vocalist D’Angelo died on October 14 at age 51 after a private battle with pancreatic cancer.

“The brilliant light of our household has dimmed his light for us in this life,” his relatives confirmed. “After a prolonged and courageous struggle with cancer, we are deeply saddened to declare that Michael D’Angelo Archer, recognized by his followers around the world as D’Angelo, has been taken from us.”

D’Angelo left an indelible mark on the music industry with his pioneering modern soul style and partnerships with high-profile artists.

He released his debut album, “Brown Sugar,” in the mid-nineties to immediate acclaim. The album achieved the fourth spot on the R&B charts, went platinum later that year, and received multiple Grammy nominations.

However, it was his second album, “Voodoo,” in the year 2000 that boosted his music career into the limelight. The album debuted at No. 1 on both the R&B charts and the Billboard 200. He received two Grammy Awards: Top R&B Record and Outstanding Male Vocal Performance for “Untitled (How Does It Feel).”

The visual for “Untitled (How Does It Feel)” solidified D’Angelo’s reputation as a sex symbol, albeit a reluctant one, in the public consciousness. The personal depiction featured the singer, famously bare to his waist, performing directly into the camera.

D’Angelo retreated from the public eye after releasing Voodoo and openly battled with substance abuse. In 2005, he was part of a severe vehicle accident that put him in grave health.

Over ten years later, his last record, “Black Messiah” (2014), confirmed his enduring appeal with another top chart entry on the R&B chart and a Grammy for Top R&B Record.

Again, in his own mysterious way, D’Angelo made only a few public appearances in the subsequent period.

The singer was scheduled as a top act for the 2025 Roots Picnic festival, but his appearance was called off, due to an “unforeseen medical delay.”

Although details are sparse about D’Angelo’s well-being in the weeks leading up to his passing, he had reportedly been in the hospital for months and in hospice for two weeks.

D’Angelo’s passing is a stark reminder of the harmful impact of pancreatic malignancy, one of the most deadly and least preventable types of the illness, on a brilliant talent whose life was cut short.

“We are grieved that he can only leave cherished moments with his family, but we are forever thankful for the legacy of extraordinarily moving songs he has left us,” his kin expressed.

Pancreatic Malignancy: Lethal and Rarely Preventable

Pancreatic malignancy affects the digestive organ, a tiny gland that generates the hormone insulin and is vital in breaking down food, among other functions. The size and location of the pancreas in the human system make it more challenging to identify cancer.

Although this cancer accounts for only about 3% of cancer diagnoses each year in the U.S., it is causes seven percent of malignancy fatalities.

Almost 70,000 individuals will be diagnosed with this condition and about 52,000 will succumb to the disease in 2025.

“Pancreatic cancer is one of the most lethal diseases, with an aggressive tumor and poor prognosis. We have few and ineffective therapies, and a narrow opportunity to make a meaningful impact on the well-being of patients,” noted a medical oncologist.

Since pancreatic cancer rarely causes early symptoms, it’s frequently diagnosed only once the condition is late-stage. Although a individual has symptoms they are usually vague and may be confused with a several common illnesses.

“Currently, there is no good way to identify pancreatic cancer in the early stages, apart from listening to your body and speaking with your physician if there are unfamiliar signs,” explained a health expert.

Common symptoms of this disease encompass:

• discomfort in the stomach or back
• weight loss
• jaundice
• reduced hunger
• dark urine
• pale or fatty bowel movements
• diarrhea
• excessive hunger or thirst
• feeling sick

At age 51, D’Angelo’s demise is an exception, as pancreatic cancer is most common in adults in the sixty-five to seventy-five age bracket. However, many cancers, including this type, have become increasingly prevalent among younger adults.

“This disease identified prior to fifty is deemed rare, yet alarmingly, doctors are noticing a growing number of younger individuals affected by this condition,” commented a specialist.

Genetic Background Affects Cancer Risk

In the absence of reliable screening tools for this malignancy, experts emphasized the importance of understanding your family’s health background. Some risk factors, such as tobacco use and obesity also play a role in the development of pancreatic cancer.

Black individuals have the greatest occurrence of this malignancy in the U.S. and are more prone to be found to have untreatable disease.

“The initial action toward lowering one’s risk of this condition is assessing individual susceptibility. Individuals should review their genetic background, genetic background, and health issues, such as blood sugar disease, long-term pancreas inflammation, or overweight that may increase their susceptibility,” said a specialist.

Inherited genetic elements are associated with as much as ten percent of all this malignancy instances. If a relative in your household has had this disease, you may want to think about DNA analysis.

“For individuals with a family history of pancreatic cancer or those carrying high risk genetic mutations, checking may involve advanced imaging such as magnetic resonance imaging (MRI) or internal ultrasound to detect initial alterations in the pancreas,” he explained.

For those wishing to lower their chance, habit adjustments may have an effect. The most effective step you can take to lower your risk of this disease is to stop tobacco use, and if you are a non-smoker, stay away altogether.

Excessive drinking is associated with pancreatitis, a contributing element for this malignancy, so limiting or abstaining from alcohol may assist lower your chance.

Managing your body mass or shedding pounds may also aid reduce your risk. People with obesity are twenty percent more prone to develop this disease. This malignancy also is more frequent in people with blood sugar issues, and weight loss can also reduce the chance of type 2 diabetes.

In spite of this disease’s poor prognosis, there is reason for optimism.

“We are doing better with therapies and newer combination chemotherapy. There are developing precision medicines that are already showing results,” remarked a expert.

For numerous individuals, however, awareness about this rare but {dev